HomeCompareTOEAF vs JNJ

TOEAF vs JNJ: Dividend Comparison 2026

TOEAF yields 1.63% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOEAF wins by $27.61M in total portfolio value
10 years
TOEAF
TOEAF
● Live price
1.63%
Share price
$16.74
Annual div
$0.27
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.64M
Annual income
$24,732,099.77
Full TOEAF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — TOEAF vs JNJ

📍 TOEAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOEAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOEAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOEAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOEAF
Annual income on $10K today (after 15% tax)
$138.88/yr
After 10yr DRIP, annual income (after tax)
$21,022,284.80/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, TOEAF beats the other by $21,018,247.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOEAF + JNJ for your $10,000?

TOEAF: 50%JNJ: 50%
100% JNJ50/50100% TOEAF
Portfolio after 10yr
$13.84M
Annual income
$12,368,424.83/yr
Blended yield
89.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TOEAF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
14.3
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOEAF buys
0
JNJ buys
0
No recent congressional trades found for TOEAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOEAFJNJ
Forward yield1.63%2.14%
Annual dividend / share$0.27$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$27.64M$30.5K
Annual income after 10y$24,732,099.77$4,749.88
Total dividends collected$27.39M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TOEAF vs JNJ ($10,000, DRIP)

YearTOEAF PortfolioTOEAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,027$326.77$10,594$274.49+$433.00TOEAF
2$12,472$673.51$11,294$360.69+$1.2KTOEAF
3$14,769$1,423.91$12,133$476.91+$2.6KTOEAF
4$18,955$3,151.67$13,156$635.42+$5.8KTOEAF
5$27,842$7,560.45$14,432$854.61+$13.4KTOEAF
6$50,548$20,757.63$16,056$1,162.76+$34.5KTOEAF
7$124,529$70,442.21$18,175$1,604.53+$106.4KTOEAF
8$457,617$324,370.98$21,009$2,252.68+$436.6KTOEAF
9$2,717,673$2,228,023.22$24,911$3,229.73+$2.69MTOEAF
10$27,640,010$24,732,099.77$30,458$4,749.88+$27.61MTOEAF

TOEAF vs JNJ: Complete Analysis 2026

TOEAFStock

Toei Animation Co.,Ltd. engages in the production, marketing, and licensing of animation products in Japan and internationally. It plans and produces various animated TV shows and films through various media, including TV, movie theaters, Blu-ray discs, DVDs, streaming platforms, and smartphone apps. The company also develops and sells character products, such as toys, apparel, stationary, game apps, and campaigns, as well as engages in the goods sales and events business. It owns 253 movies, 228 TV programs, and 13,000 episodes of content. The company was founded in 1948 and is based in Tokyo, Japan.

Full TOEAF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TOEAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOEAF vs SCHDTOEAF vs JEPITOEAF vs OTOEAF vs KOTOEAF vs MAINTOEAF vs ABBVTOEAF vs MRKTOEAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.